Philip R Hamann Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

7/2007	CD20-specific antibody-targeted chemotherapy of non-Hodgkin's B-cell lymphoma using calicheamicin-conjugated rituximab.
1/2006	Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin's B-cell lymphoma.
12/2004	Potent and specific antitumor efficacy of CMC-544, a CD22-targeted immunoconjugate of calicheamicin, against systemically disseminated B-cell lymphoma.
3/2004	Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip R Hamann Research Topics

Disease

9	Neoplasms (Cancer) 06/2011 - 01/2002
4	B-Cell Lymphoma (Lymphoma, B Cell) 07/2007 - 03/2004
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2006 - 01/2002
2	Carcinoma (Carcinomatosis) 03/2005 - 07/2004
2	Leukemia 01/2002 - 01/2002
1	Lung Neoplasms (Lung Cancer) 06/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2006
1	Arthritis (Polyarthritis) 10/2005
1	Breast Neoplasms (Breast Cancer) 03/2005
1	Paralysis (Palsy) 12/2004

Drug/Important Bio-Agent (IBA)

10	CalicheamicinsIBA 07/2007 - 01/2002
6	Immunoconjugates (Immunoconjugate)IBA 06/2011 - 03/2004
5	AntigensIBA 06/2011 - 07/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2005 - 01/2002
3	Gemtuzumab (Mylotarg)FDA Link 03/2006 - 01/2002
3	Inotuzumab OzogamicinIBA 01/2006 - 03/2004
2	Rituximab (Mabthera)FDA Link 07/2007 - 01/2006
2	AmidesIBA 03/2005 - 03/2005
2	CarbohydratesIBA 03/2005 - 01/2002
2	HydrazinesIBA 07/2004 - 03/2004
1	Cytotoxins (Cytolysins)IBA 07/2007
1	AcidsIBA 07/2007
1	Immunoglobulins (Immunoglobulin)IBA 03/2006
1	Collagen Type II (Type II Collagen)IBA 10/2005
1	Monoclonal AntibodiesIBA 03/2005
1	hCTMO1-calicheamicinIBA 03/2005
1	Cisplatin (Platino)FDA LinkGeneric 03/2005
1	Immunoglobulin G (IgG)IBA 03/2005
1	hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazideIBA 07/2004
1	Lewis Y antigenIBA 07/2004
1	DNA (Deoxyribonucleic Acid)IBA 03/2004

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 07/2007 - 03/2004
1	Therapeutics 03/2006
1	Injections 12/2004